Christopher M. Lauderback

Christopher Lauderback has a strong background in the pharmaceutical industry with experience in various roles. Christopher began their career at New River Pharmaceuticals as a Senior Scientist and later became an Associate Director. Christopher then worked at Airbase Therapeutics as the Director of Product Development. Lauderback went on to join Sigma-Tau Pharmaceuticals as a Senior Manager, focusing on CMC. Most recently, they have served as the Vice President at KemPharm, Inc.

Christopher Lauderback completed their Bachelor of Science in Chemistry from Emory & Henry College from 1992 to 1996. Following this, they pursued a PhD in Chemistry from the University of Kentucky, completing it from 1996 to 2001.